| |  Online-Ressource |
|---|
| Verfasst von: | Khandanpour, Cyrus [VerfasserIn]  |
|---|
| | Eisfeld, Christine [VerfasserIn] |
|---|
| | Nimmagadda, Subbaiah Chary [VerfasserIn] |
|---|
| | Raab, Marc-Steffen [VerfasserIn] |
|---|
| | Weinhold, Niels [VerfasserIn] |
|---|
| | Seckinger, Anja [VerfasserIn] |
|---|
| | Hose, Dirk [VerfasserIn] |
|---|
| | Jauch, Anna [VerfasserIn] |
|---|
| | Försti, Asta [VerfasserIn] |
|---|
| | Hemminki, Kari [VerfasserIn] |
|---|
| | Hielscher, Thomas [VerfasserIn] |
|---|
| | Hummel, Manuela [VerfasserIn] |
|---|
| | Lenz, Georg [VerfasserIn] |
|---|
| | Goldschmidt, Hartmut [VerfasserIn] |
|---|
| | Huhn, Stefanie [VerfasserIn] |
|---|
| Titel: | Prevalence of the GFI1-36N SNP in multiple myeloma patients and its impact on the prognosis |
|---|
| Verf.angabe: | Cyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, Marc S. Raab, Niels Weinhold, Anja Seckinger, Dirk Hose, Anna Jauch, Asta Försti, Kari Hemminki, Thomas Hielscher, Manuela Hummel, Georg Lenz, Hartmut Goldschmidt and Stefanie Huhn |
|---|
| E-Jahr: | 2021 |
|---|
| Jahr: | 25 October 2021 |
|---|
| Umfang: | 8 S. |
|---|
| Fussnoten: | Gesehen am 22.12.2021 |
|---|
| Titel Quelle: | Enthalten in: Frontiers in oncology |
|---|
| Ort Quelle: | Lausanne : Frontiers Media, 2011 |
|---|
| Jahr Quelle: | 2021 |
|---|
| Band/Heft Quelle: | 11(2021) vom: 25. Okt., Artikel-ID 757664, Seite 1-8 |
|---|
| ISSN Quelle: | 2234-943X |
|---|
| Abstract: | Transcription factor Growth Factor Independence 1 (GFI1) regulates the expression of genes important for survival, proliferation and differentiation of hematopoietic cells. A single nucleotide polymorphism (SNP) variant of GFI1 (GFI1-36N: serine replaced by asparagine at position 36), has a prevalence of 5-7% among healthy Caucasians and 10-15% in patients with myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) predisposing GFI-36N carriers to these diseases. Since GFI1 is implicated in B cell maturation and plasma cell (PC) development, we examined its prevalence in patients with multiple myeloma (MM), a haematological malignancy characterized by expansion of clonal PCs. Strikingly, as in MDS and AML, we found that the GFI1-36N had a higher prevalence among MM patients compared to the controls. In subgroup analyses, GFI1-36N correlates to a shorter overall survival of MM patients characterized by the presence of t(4;14) translocation and gain of 1q21 (≤3 copies). MM patients carrying gain of 1q21 (≥3 copies) demonstrated poor progression free survival. Furthermore, gene expression analysis implicated a role for GFI1-36N in epigenetic regulation and metabolism, potentially promoting the initiation and progression of MM. |
|---|
| DOI: | doi:10.3389/fonc.2021.757664 |
|---|
| URL: | kostenfrei: Volltext: https://doi.org/10.3389/fonc.2021.757664 |
|---|
| | kostenfrei: Volltext: https://www.frontiersin.org/article/10.3389/fonc.2021.757664 |
|---|
| | DOI: https://doi.org/10.3389/fonc.2021.757664 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1783511206 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
| |
|
|---|
| | |
|---|
| Lokale URL UB: |  Zum Volltext |
|---|
Prevalence of the GFI1-36N SNP in multiple myeloma patients and its impact on the prognosis / Khandanpour, Cyrus [VerfasserIn]; 25 October 2021 (Online-Ressource)
